Presentation is loading. Please wait.

Presentation is loading. Please wait.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Published byIris Chandler Modified over 6 years ago

Similar presentations

Presentation on theme: "Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection."— Presentation transcript:

1 Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection Fraction  Ramdas G. Pai, MD, Padmini Varadarajan, MD, Anees Razzouk, MD  The Annals of Thoracic Surgery  Volume 86, Issue 6, Pages (December 2008) DOI: /j.athoracsur Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 The Kaplan-Meier survival curves of low ejection fraction (EF ≤ 0.35) patients with and without aortic valve replacement. (n = 194; AVR = aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Results of sensitivity analysis in low ejection fraction group. (A) ≤ 30 days eliminated; (B) ≤ 365 days eliminated. (AVR = aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Effect of aortic valve replacement (AVR) on survival in patients with an ejection fraction ≤ 0.20 (n = 72). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Effect of aortic valve replacement (AVR) on survival as a function of mean transaortic gradient in low EF patients. (A) EF ≤ 0.35, MG ≤ 30 mm Hg; (B) EF ≤ 0.35, MG > 30 mm Hg. (EF = ejection fraction; MG = mean gradient.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Kaplan-Meier survival curves of patients with without aortic valve replacement (AVR) in severe aortic stenosis patients with transvalvular gradients of ≤ 30 mm Hg. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

7 Fig 6 Sensitivity analysis with persistent aortic valve replacement (AVR) benefit with patients with events until 2 years eliminated in the low gradient group. (A) Patients events in ≤ 30 days eliminated; (B) Patients events in ≤ 90 days eliminated; (C) Patients events in ≤ 1 year eliminated; (D) Patients events in ≤ 2 years eliminated. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

8 Fig 7 Effect of aortic valve replacement (AVR) on survival as a function of left ventricular ejection fraction (EF) in the low gradient group. (A) Severe aortic stenosis (AS), low gradient, EF < 0.35; (B) severe AS, low gradient, EF 0.35 to 0.54; (C) Severe AS, low gradient, EF ≥ (AS = aortic stenosis.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection."

Similar presentations

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Left Thoracotomy: An Ideal Approach for Mitral Valve Replacement in Patient With Severe Chest Wall Deformity  Juan G. Bastidas, MD, Anees J. Razzouk,

Left Thoracotomy: An Ideal Approach for Mitral Valve Replacement in Patient With Severe Chest Wall Deformity  Juan G. Bastidas, MD, Anees J. Razzouk,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Reply The Annals of Thoracic Surgery

Reply The Annals of Thoracic Surgery
Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.

Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Serial Changes of Hemodynamic Performance With Medtronic Hall Valve in Aortic Position  Yang Hyun Cho, MD, Dong Seop Jeong, MD, PhD, Pyo Won Park, MD,

Serial Changes of Hemodynamic Performance With Medtronic Hall Valve in Aortic Position  Yang Hyun Cho, MD, Dong Seop Jeong, MD, PhD, Pyo Won Park, MD,
Improved Mitral Valve Performance After Transapical Aortic Valve Implantation  Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,

Improved Mitral Valve Performance After Transapical Aortic Valve Implantation  Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,
Valve Replacement for Severe Aortic Stenosis With Low Transvalvular Gradient and Left Ventricular Ejection Fraction Exceeding 0.50  Giuseppe Tarantini,

Valve Replacement for Severe Aortic Stenosis With Low Transvalvular Gradient and Left Ventricular Ejection Fraction Exceeding 0.50  Giuseppe Tarantini,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Dhaval Chauhan, MD, Alexis K

Dhaval Chauhan, MD, Alexis K
Impact of the Improvement of Valve Area Achieved With Aortic Valve Replacement on the Regression of Left Ventricular Hypertrophy in Patients With Pure.

Impact of the Improvement of Valve Area Achieved With Aortic Valve Replacement on the Regression of Left Ventricular Hypertrophy in Patients With Pure.

Similar presentations

Ads by Google